CNN || FDA & CDC

CDC: Opioid use high among reproductive age women

Posted on: 22/01/2015 - 18:00

Nearly 40% of a reproductive age women enrolled in Medicaid and nearly 30% of those with private insurance filled an opioid prescription between 2008 ... More »

Field of Interest: Pulmonology

Type: News Item

FDA panel addresses neurologic risks of epidural steroid injections

Posted on: 26/11/2014 - 15:34

SILVER SPRING, MD. – A Food and Drug Administration advisory panel recommended that a contraindication or warning be added to the labels of injectable corticosteroids, specifically pertaining to...

Field of Interest: Rheumatology

Type: News Item

FDA approves new abuse-prevention labeling for extended-release Embeda

Posted on: 18/10/2014 - 16:57

The Food and Drug Administration has approved new labeling for the opioid analgesic Embeda to include information about the drug’s abuse-preventive properties, the agency announced Oct. 17. The...

Field of Interest: Oncology

Type: News Item

CDC: Opioid use high among reproductive age women

FDA panel addresses neurologic risks of epidural steroid injections

FDA approves new abuse-prevention labeling for extended-release Embeda

Newsletters

Latest Newsletters

You are here

CNN || FDA & CDC

CDC: Opioid use high among reproductive age women

FDA panel addresses neurologic risks of epidural steroid injections

FDA approves new abuse-prevention labeling for extended-release Embeda

Newsletters

Latest Newsletters